ArticleFrontiers in neurology2025
Flexible and Adjustable Transparent Sheath Endoport combine with "two-in-one" neuroendoscopic for minimally invasive evacuation of irregular intracerebral hemorrhage.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Irregular intracerebral hematomas (ICH), characterized by complex shapes or multi-regional involvement, pose challenges for traditional neuroendoscopy due to rigid endoport limitations. We introduce a Flexible and Adjustable Transparent Sheath Endoport (FATSE) combined with a "two-in-one" neuroendoscopic technique (stereotactic aspiration plus endoscopic evacuation) to address these challenges. Methods: In 54 patients with irregular ICH (multi-regional, intraventricular, or width-to-length ratio < 50% on CT), we evaluated the FATSE approach. Patients were stratified into four groups by hematoma location: basal ganglia, lobar, thalamic, or intraventricular. Results: The mean hematoma evacuation rate was 95.0% (range 94.0-98.3%), with lobar/intraventricular hemorrhages (Group B) achieving the highest rate (95.2%). Median Glasgow Coma Scale (GCS) score improved by 5.2 points (7.2 to 12.4). There was 0% mortality, 1.9% rebleeding, and 5.6% pneumonia rates. The adjustable sheath enabled 360° cavity inspection in all cases. Conclusion: The FATSE technique offers superior evacuation rates (95.0% vs. 85-90% with rigid endoports) and improved outcomes for irregular ICH, representing a paradigm shift in minimally invasive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.